The 12th Invest in ME Research Conference June, 2017, Part 2
MEMum presents the second article in a series of three about the recent 12th Invest In ME International Conference (IIMEC12) in London.
Discuss the article on the Forums.

Hemispherx Biopharma (Ampligen) investor update Sept 2014

Discussion in 'Antivirals, Antibiotics and Immune Modulators' started by catly, Sep 10, 2014.

  1. catly

    catly Senior Member

    outside of NYC
    I don't see where this was posted anywhere:
    Hemispherx Biopharma to Present at the 16th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th

    Sorry, I don't have time today to provide a summary but you can view the webcast from today by following this link to their website and then clicking on the link to the presentation on the left. It will be up for 90 days.
  2. jstefl

    jstefl Senior Member

    Brookfield, Wisconsin
    Hemispherix Biopharma's stock was up a bit today on the news that Ampligen may be useful in the treatment of Ebola.

    The headlines on their website say that U S Army scientists finds a 100% survival rate in Ebola Virus rodent study. This is in contrast to a 100% death rate for the placebo group.

    Good news for any mouse that gets Ebola at least. If these results transfer to humans, Ampligen may finally become available.


See more popular forum discussions.

Share This Page